sunitinib,BEZUCLASTINIB
pfizer,Cogent Biosciences
['sunitinib']
 and don't miss the results from 's work part 1 of the phase 3 peak study on safety, pharmacokinetics + clinical activity of bezuclastinib + sunitinib: #crukfunded (2/4)
We're here to support our broad cancer research community of 4,000 scientists and clinicians. For general Cancer Research UK news & fundraising follow @CR_UK